ASCENT Study: Impact of Sacituzumab Govitecan on Metastatic TNBC

Shay Elkins, a patient with metastatic triple-negative breast cancer, discussed her experience with second-line treatment. Dr. Noor provided insights into the positive outcomes from the ASCENT study.